WIN Consortium Gets $3.9M to Launch International Personalized Cancer Treatment Trials | GenomeWeb

NEW YORK (GenomeWeb News) – The WIN Consortium, an International personalized medicine initiative, will use €3 million ($3.9 million) in funding from the European Union to launch an effort to provide tailored cancer treatment regimens to patients based on genetic analysis, the consortium said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.